American Healthcare REIT (NYSE:AHR - Get Free Report) had its target price lifted by equities research analysts at Royal Bank Of Canada from $56.00 to $61.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm presently has an "outperform" rating on the stock. Royal Bank Of Canada's price target suggests a potential upside of 13.20% from the stock's current price.
Other equities research analysts also recently issued reports about the company. Weiss Ratings downgraded American Healthcare REIT from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Tuesday, June 2nd. Compass Point assumed coverage on American Healthcare REIT in a report on Tuesday, July 21st. They set a "buy" rating and a $70.00 price target for the company. Citigroup reaffirmed a "buy" rating and issued a $65.00 price objective (up from $55.00) on shares of American Healthcare REIT in a research note on Monday. Citizens Jmp upped their price objective on American Healthcare REIT from $60.00 to $65.00 and gave the stock a "market outperform" rating in a report on Monday, July 27th. Finally, Scotiabank lowered their target price on American Healthcare REIT from $59.00 to $51.00 and set a "sector outperform" rating for the company in a research report on Thursday, June 18th. Twelve research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $60.08.
Read Our Latest Analysis on AHR
American Healthcare REIT Price Performance
AHR traded up $0.28 during trading on Friday, hitting $53.88. 654,461 shares of the company traded hands, compared to its average volume of 2,951,230. The company has a market cap of $10.38 billion, a PE ratio of 79.27, a P/E/G ratio of 1.67 and a beta of 0.76. The stock's 50-day simple moving average is $52.74 and its two-hundred day simple moving average is $50.90. American Healthcare REIT has a 1 year low of $39.68 and a 1 year high of $58.70. The company has a current ratio of 0.48, a quick ratio of 0.45 and a debt-to-equity ratio of 0.24.
American Healthcare REIT (NYSE:AHR - Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.16 EPS for the quarter, topping the consensus estimate of $0.14 by $0.02. The business had revenue of $674.25 million for the quarter, compared to analysts' expectations of $645.30 million. American Healthcare REIT had a net margin of 4.84% and a return on equity of 3.63%. The business's quarterly revenue was up 24.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.42 EPS. American Healthcare REIT has set its FY 2026 guidance at 2.150-2.190 EPS. As a group, sell-side analysts anticipate that American Healthcare REIT will post 2.17 earnings per share for the current fiscal year.
Insider Transactions at American Healthcare REIT
In other news, CFO Brian Peay sold 25,000 shares of the firm's stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $50.70, for a total value of $1,267,500.00. Following the completion of the sale, the chief financial officer directly owned 152,700 shares of the company's stock, valued at $7,741,890. This trade represents a 14.07% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Mark E. Foster sold 2,500 shares of American Healthcare REIT stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $48.58, for a total value of $121,450.00. Following the completion of the transaction, the executive vice president owned 52,995 shares of the company's stock, valued at approximately $2,574,497.10. This trade represents a 4.50% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 29,500 shares of company stock valued at $1,485,590. 0.75% of the stock is owned by insiders.
Institutional Trading of American Healthcare REIT
A number of institutional investors have recently bought and sold shares of AHR. Manning & Napier Advisors LLC purchased a new stake in shares of American Healthcare REIT in the second quarter valued at $28,000. Bank of New York Mellon Corp purchased a new position in shares of American Healthcare REIT during the 2nd quarter worth about $77,999,000. E. Ohman J or Asset Management AB bought a new position in American Healthcare REIT during the 2nd quarter valued at about $2,906,000. First Heartland Consultants Inc. grew its holdings in American Healthcare REIT by 12.0% during the 2nd quarter. First Heartland Consultants Inc. now owns 5,955 shares of the company's stock valued at $311,000 after purchasing an additional 638 shares during the last quarter. Finally, GAMMA Investing LLC raised its position in American Healthcare REIT by 7.3% in the 2nd quarter. GAMMA Investing LLC now owns 3,264 shares of the company's stock worth $170,000 after purchasing an additional 222 shares during the period. 16.68% of the stock is currently owned by institutional investors.
About American Healthcare REIT
(
Get Free Report)
American Healthcare REIT, Inc NYSE: AHR was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare‐related properties across the United States. The company's portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long‐term net lease or triple‐net lease structures designed to provide stable, predictable rental income.
Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high‐growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider American Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.
While American Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.